Hinova Pharmaceuticals Inc. A (688302) — Net Asset Momentum
Hinova Pharmaceuticals Inc. A (688302) recorded a net asset momentum of -12.8% as of December 2024, with net assets of CN¥1.19 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Hinova Pharmaceuticals Inc. A to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hinova Pharmaceuticals Inc. A Net Asset Momentum (2019–2024)
This chart tracks Hinova Pharmaceuticals Inc. A's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -12.8%, with net assets of CN¥1.19 Billion CNY as of December 2024. Read Hinova Pharmaceuticals Inc. A debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hinova Pharmaceuticals Inc. A (2019–2024)
The table below shows the complete annual net asset history for Hinova Pharmaceuticals Inc. A from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Hinova Pharmaceuticals Inc. A (688302) market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.19 Billion | CN¥1.36 Billion | CN¥169.33 Million | ▼ -12.8% |
| 2023 | CN¥1.37 Billion | CN¥1.49 Billion | CN¥124.47 Million | ▼ -13.8% |
| 2022 | CN¥1.59 Billion | CN¥1.74 Billion | CN¥149.68 Million | ▲ +101.0% |
| 2021 | CN¥788.76 Million | CN¥982.35 Million | CN¥193.59 Million | ▼ -20.0% |
| 2020 | CN¥986.15 Million | CN¥1.19 Billion | CN¥202.33 Million | ▲ +2855.8% |
| 2019 | CN¥-35.78 Million | CN¥44.72 Million | CN¥80.50 Million | — |